Previous 10 | Next 10 |
Agreement Important Precursor to Next Step, Enrollment AIM is a Study Collaborator and Financial Supporter OCALA, FL / ACCESSWIRE / July 9, 2020 / AIM ImmunoTech (NYSE AMERICAN:AIM), today announced that it has entered into a clinical trial agreement (CTA) with Roswell Park Compr...
ST HELIER, Jersey, July 09, 2020 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc ("Caledonia" or the "Company") (NYSE AMERICAN & AIM: CMCL) announces quarterly gold production from the Blanket Mine ("Blanket") in Zimbabwe for the quarter ended June 30, 2020 ("Q2 2020" or the...
TORONTO, July 09, 2020 (GLOBE NEWSWIRE) -- Galantas Gold Corporation (the "Company" or “Galantas”) ( TSXV & AIM : Symbol GAL ) is pleased to announce its financial results for the Quarter ended March 31, 2020. Financial Highlights Highlights of the first quarter 2020 ...
NICOSIA, CYPRUS / ACCESSWIRE / July 9, 2020 / Atalaya Mining Plc (AIM:ATYM)(TSX:AYM), the European mining and development company, announces that in accordance with the Company's Long Term Inventive Plan 2020 (the "LTIP20") which was approved by shareholders at the Annual General Meeting on ...
GUILDFORD, SURREY / ACCESSWIRE / July 8, 2020 / ANGLE plc (OTC PINK:ANPCY)(AIM:AGL): TR-1: Standard form for notification of major holdings This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a P...
GUILDFORD, SURREY / ACCESSWIRE / July 8, 2020 / (OTC Pink Sheets:ANPCY)(AIM:AGL) TR-1: Standard form for notification of major holdings This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Prima...
GUILDFORD, SURREY / ACCESSWIRE / July 8, 2020 / OTC Pink Sheets:ANPCY, AIM:AGL TR-1: Standard form for notification of major holdings This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary...
THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR IMMEDIATE RELEASE AMRYT PHARMA PLC (“ Amryt ” or the “ Company ”) AMRYT LISTED O...
SINGAPORE / ACCESSWIRE / July 8, 2020 / (AIM:JSE)(TSXV:JSE) TR-1: Standard form for notification of major holdings Notes i Please note that national forms may vary due to specific national legislation (Article 3(1a) of Directive 2004/109/EC) as for instance the applicable thresh...
Company intends to cease focus on screening and testing products business Thorofare, New Jersey, July 07, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced with its partner,...
News, Short Squeeze, Breakout and More Instantly...
OCALA, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the publication of new pre-clinical data concerning the company’s drug Ampligen as part of a combinational therapy in the...
OCALA, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Pitch Con...
OCALA, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Lunch Break Series ...